Paper
Crystal structure of (R)-6-fluoro-2-[(S)-oxiran-2-yl]chroman
Published Jul 8, 2015 · Yoann Rousselin, Hugo Lauréano, Alexandre Clavel
Acta Crystallographica Section E: Crystallographic Communications
1
Citations
0
Influential Citations
Abstract
The title compound, C11H11FO2, is a building block in the synthesis of the active pharmaceutical ingredient dl-nebivolol. The synthesis starting from the enantiomerically pure (R)-6-fluoro-4-oxo-3,4-dihydro-2H-chromene-2-carboxylic acid resulted in a mixture of two stereoisomers, namely (R)-6-fluoro-2-[(S)-oxiran-2-yl]chroman and (R)-6-fluoro-2-[(R)-oxiran-2-yl]chroman. The mixture was separated by column chromatography but only one stereoisomer crystallized. The X-ray structure analysis revealed that the solid consisted of the R,S isomer. A similar procedure was repeated for (S)-6-fluoro-4-oxo-3,4-dihydro-2H-chromene-2-carboxylic acid and, in this case, the S,R isomer was produced as a crystalline solid. Thus, all four stereoisomers of the title epoxide were obtained and their absolute configuration was assigned. The crystal studied was refined as an inversion twin.
The crystal structure of (R)-6-fluoro-2-[(S)-oxiran-2-yl]chroman reveals all four stereoisomers and their absolute configuration, aiding in the synthesis of dl-nebivolol.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...